New Stock News | Jinge Biotech Plans to List on the Hong Kong Stock Exchange, CSRC Requires Additional Explanation on the Reasons for New Shareholders Investing in the Company in the Past 12 Months and Other Matters.

Wisdom Financial APP learned that on September 12, the China Securities Regulatory Commission announced the "Supplementary Materials Requirement for Overseas Issuance and Listing (September 5, 2025 - September 11, 2025)". The CSRC requires Jingeze Biology to provide additional explanations on the reasons for the entry of new shareholders in the past 12 months. It is reported that Jingeze Biology has submitted an application for listing on the main board of the Hong Kong Stock Exchange on June 27, 2025, with China International Capital Corporation and Guoyuan International as joint sponsors.